Dustin S. Sjuts - Dec 15, 2023 Form 4 Insider Report for Revance Therapeutics, Inc. (RVNC)

Role
President
Signature
/s/ Dwight Moxie, Attorney-in-Fact
Stock symbol
RVNC
Transactions as of
Dec 15, 2023
Transactions value $
-$38,073
Form type
4
Date filed
12/18/2023, 04:32 PM
Previous filing
Aug 15, 2023
Next filing
Jan 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVNC Common Stock Tax liability -$38.1K -4.71K -2.91% $8.08 157K Dec 15, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares withheld by and surrendered to the Issuer on December 15, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of a Restricted Stock award (the "RSA") for 11,973 shares. The RSA vests in three equal annual installments from December 15, 2021.